Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Venous Thromboembolism in Cancer Patients”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Post-approval studies (Phase 4)Study completedNCT02958969
What this trial is testing

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Who this might be right for
Venous ThromboembolismMultiple Myeloma
Gregory Piazza 50
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Not applicableStudy completedNCT05461807
What this trial is testing

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsVenous ThromboembolismCancer
Bayer 2,437
Large-scale testing (Phase 3)Study completedNCT03080883
What this trial is testing

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
Academic and Community Cancer Research United 370
Not applicableNot Yet RecruitingNCT07372716
What this trial is testing

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Who this might be right for
ThrombosisCancerThrombosis, Deep Vein+3 more
Ottawa Hospital Research Institute 700
Not applicableUnknownNCT02017743
What this trial is testing

Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Trio Grup Clinical Research 200
Not applicableLooking for participantsNCT06284343
What this trial is testing

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Who this might be right for
Cancer-associated ThrombosisVenous ThromboembolismGynecologic Cancer+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,800
Large-scale testing (Phase 3)Study completedNCT01130025
What this trial is testing

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 900
Not applicableStudy completedNCT01855698
What this trial is testing

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Who this might be right for
Hematologic NeoplasmAcute LeukemiaMyelodysplastic Syndrome+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 99
Not applicableStudy completedNCT05150938
What this trial is testing

Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer Patients
Bayer 5,737
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Not applicableStudy completedNCT03114618
What this trial is testing

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Who this might be right for
Cancer-associated ThrombosisGenetic Predisposition
Andres muñoz 416
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Large-scale testing (Phase 3)Not Yet RecruitingNCT07160686
What this trial is testing

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Who this might be right for
Thromboprophylaxis
University of Birmingham 1,456
Not applicableStudy completedNCT01362933
What this trial is testing

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Who this might be right for
NeoplasmsVenous Thromboembolism
Floralis 502
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00981903
What this trial is testing

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous ThromboembolismCancer
University of Southern California 131
Post-approval studies (Phase 4)Study completedNCT04072068
What this trial is testing

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy

Who this might be right for
ThromboembolismCancer
Gruppo Oncologico Italiano di Ricerca Clinica 150
Large-scale testing (Phase 3)Study completedNCT02746185
What this trial is testing

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

Who this might be right for
NeoplasmVenous Thromboembolism
Assistance Publique - Hôpitaux de Paris 159
Load More Results